000			03387cam a2200421Ii 4500
988			_aSpringer_Medicine_2017
999			_c95193 _d95193 _x1
001			95193
003			ES-MaUEC
005			20230102112651.0
006			m o d
007			cr cnu|||unuuu
008			170110s2017 ja a o 000 0 eng d
020			_a4431560572
020			_a4431560599 _q(electronic bk.)
020			_a9784431560579
020			_a9784431560593 _q(electronic bk.)
020			_z9784431560579 _q(print)
035			_a(OCoLC)967982013 _z(OCoLC)974651430 _z(OCoLC)981019081 _z(OCoLC)981817078 _z(OCoLC)992844493 _z(OCoLC)1005758256 _z(OCoLC)1011853481
040			_aN$T _cN$T _dIDEBK _dGW5XE _dN$T _dOCLCF _dUAB _dNJR _dYDX _dUPM _dOCLCO _dIOG _dOCLCO _dVT2 _dMERER _dESU _dZ5A _dOCLCO _dJBG _dIAD _dOCLCO _dICW _dOCLCO _dICN _dOCLCQ _dOCLCO _dOTZ _dOCLCQ _dOCLCO _dOCLCQ _dU3W _dOCLCQ _dES-MaUEC _bspa
050		4	_aRC388.5 _b2017 EB
245	0	0	_aCell therapy against cerebral stroke : _bcomprehensive reviews for translational researches and clinical trials _cKiyohiro Houkin, Koji Abe, Satoshi Kuroda, editors.
264		1	_aTokyo, Japan _bSpringer _c2017
300			_a1 recurso en línea (x, 156 páginas) _bilustraciones (algunas a color)
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aSpringerLink
505	0		_aPart I. Optimal Cell Sources -- 1. Bone Marrow-Derived Mononuclear Cells -- 2. Mesenchymal Stem Cells / Bone Marrow Stromal Cells -- 3. Neural Stem Cells / Neuronal Progenitor Cells -- 4. iPS Cells / iN -- Part II. Translational Research -- 5. Cell Culture -- 6. Cell Dose, Timing and Route -- 7. Scaffold -- 8. Cell Tracking -- 9. Functional Bio-Imaging -- Part III. Clinical Trials -- 10. Review of Previous Clinical Trials and Guideline of Cell Therapy -- 11. Bone Marrow-Derived Mononuclear Cells -- 12. Mesenchymal Stem Cells.
520	3		_aThis book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke. Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity. Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy. The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan.
650		7	_aEnfermedades cerebrovasculares _2embne _0(OCoLC)fst00850322 _9150775
700	1		_aAbe, Koji, _eeditor literario
700	1		_aHoukin, Kiyohiro, _eeditor literario
700	1		_aKuroda, Satoshi, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-4-431-56059-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2018 _dz _e- _zSI